Sienna Biopharmaceuticals (SNNA) Prices 4.33M Share IPO at $15/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
Sienna Biopharmaceuticals, Inc. Announces Pricing of Initial Public Offering of Common Stock
July 26, 2017 7:30 PM EDTWESTLAKE VILLAGE, Calif., July 26, 2017 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA) today announced the pricing of the Companys initial public offering of 4,333,333 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the shares of common stock are being offered by Sienna. The Company has also granted the underwriters a 30-day option to purchase from the Company an additional 650,000 shares of common stock at the initial public offering price, less the underwriting discount. Siennas common stock has been approved for listing... More
